In a concerted response to the second surge of COVID-19 infection in the country, the Ministry of Ayush is launching a massive nationwide campaign today to distribute its proven poly herbal Ayurvedic drugs AYUSH 64 and Sidha drug Kabasura Kudineer.
The efficacy of these drugs has been proved through robust multi-centre clinical trials. The multi stakeholder campaign being launched by Union Minister Kiren Rijiju will ensure that medicines reach the needy in a transparent and efficient manner. The main collaborator in the campaign is Sewa Bharati.
It is worthwhile to note that since the COVID-19 pandemic hit the country, the Ministry of Ayush has taken several initiatives toward control and mitigation of COVID 19, while also working in close collaboration with the Ministry of Health and Family Welfare in the fight against COVID 19. With the latest initiative of the Ministry to launch a nationwide campaign for distribution of AYUSH-64 and Kabasura Kudineer, India aims to strengthen its position in the fight against COVID19 pandemic.
AYUSH-64 is recommended in National Clinical Management Protocol based on Ayurveda and Yoga which is vetted by National Task Force on COVID Management of ICMR and guidelines for Ayurveda Practitioners for COVID-19 Patients in Home Isolation. Kabasura Kudineer is included in the Guidelines for Siddha Practitioners for COVID 19 by the AYUSH Ministry.